SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/13/17 Idt Corp 10-Q 1/31/17 68:3.8M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 382K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 19K 12: R1 Document and Entity Information HTML 39K 13: R2 Consolidated Balance Sheets HTML 125K 14: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K 15: R4 Consolidated Statements of Income (Unaudited) HTML 80K 16: R5 Consolidated Statements of Comprehensive Income HTML 44K (Unaudited) 17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 117K 18: R7 Basis of Presentation HTML 24K 19: R8 Zedge Spin-Off HTML 31K 20: R9 Investment in Cornerstone Pharmaceuticals, Inc. HTML 30K 21: R10 Marketable Securities HTML 59K 22: R11 Fair Value Measurements HTML 40K 23: R12 Derivative Instruments HTML 35K 24: R13 Equity HTML 47K 25: R14 Earnings Per Share HTML 36K 26: R15 Revolving Credit Loan Payable HTML 24K 27: R16 Accrued Severance Expense HTML 21K 28: R17 Accumulated Other Comprehensive Loss HTML 32K 29: R18 Business Segment Information HTML 51K 30: R19 Commitments and Contingencies HTML 41K 31: R20 Other (Expense) Income, Net HTML 28K 32: R21 Income Taxes HTML 23K 33: R22 Recently Issued Accounting Standard Not Yet HTML 32K Adopted 34: R23 Zedge Spin-Off (Tables) HTML 26K 35: R24 Marketable Securities (Tables) HTML 87K 36: R25 Fair Value Measurements (Tables) HTML 36K 37: R26 Derivative Instruments (Tables) HTML 25K 38: R27 Equity (Tables) HTML 40K 39: R28 Earnings Per Share (Tables) HTML 45K 40: R29 Accumulated Other Comprehensive Loss (Tables) HTML 27K 41: R30 Business Segment Information (Tables) HTML 60K 42: R31 Commitments and Contingencies (Tables) HTML 28K 43: R32 Other (Expense) Income, Net (Tables) HTML 31K 44: R33 Zedge Spin-Off (Details) HTML 27K 45: R34 Investment in Cornerstone Pharmaceuticals, Inc. HTML 87K (Details) 46: R35 Marketable Securities (Details) HTML 64K 47: R36 Marketable Securities (Details 1) HTML 34K 48: R37 Marketable Securities (Details 2) HTML 44K 49: R38 Marketable Securities (Details Textual) HTML 38K 50: R39 Fair Value Measurements (Details) HTML 30K 51: R40 Fair Value Measurements (Details Textual) HTML 22K 52: R41 Derivative Instruments (Details) HTML 21K 53: R42 Equity (Details) HTML 62K 54: R43 Equity (Details Textual) HTML 60K 55: R44 Earnings Per Share (Details) HTML 33K 56: R45 Earnings Per Share (Details 1) HTML 22K 57: R46 Revolving Credit Loan Payable (Details) HTML 46K 58: R47 Accrued Severance Expense (Details) HTML 26K 59: R48 Accumulated Other Comprehensive Loss (Details) HTML 48K 60: R49 Business Segment Information (Details) HTML 42K 61: R50 Business Segment Information (Details Textual) HTML 20K 62: R51 Commitments and Contingencies (Details) HTML 28K 63: R52 Commitments and Contingencies (Details Textual) HTML 40K 64: R53 Other (Expense) Income, Net (Details) HTML 33K 65: R54 Income Taxes (Details) HTML 24K 67: XML IDEA XML File -- Filing Summary XML 117K 66: EXCEL IDEA Workbook of Financial Reports XLSX 61K 6: EX-101.INS XBRL Instance -- idt-20170131 XML 1.04M 8: EX-101.CAL XBRL Calculations -- idt-20170131_cal XML 137K 9: EX-101.DEF XBRL Definitions -- idt-20170131_def XML 382K 10: EX-101.LAB XBRL Labels -- idt-20170131_lab XML 931K 11: EX-101.PRE XBRL Presentations -- idt-20170131_pre XML 600K 7: EX-101.SCH XBRL Schema -- idt-20170131 XSD 127K 68: ZIP XBRL Zipped Folder -- 0001213900-17-002245-xbrl Zip 100K
Download this zipped .zip folder | |
Files: | idt-20170131.xml idt-20170131.xsd idt-20170131_cal.xml idt-20170131_def.xml idt-20170131_lab.xml idt-20170131_pre.xml |